Complexation equilibria have been evaluated by potentiometric titration of several biologically significant divalent metals as well
Introduction
Chelation therapy as a means of treatment for removal of metals or metalloids from the body has been used since British anti-Lewisite (2,3-dimercaptopropanol) was discovered to be an effective sequestering . 2 agent for arsenic in the early 1940's.
Subsequent development of poly(carboxylate)amines such as ethylenediaminetetraacetic acid (EDTA) and diethylenetriaminepentaacetic acid (DTPA), effective in vivo sequestering agents for a variety of metal ions,3 has spurred the search for the development of other effective chelating agents.
Although the synthetic chelating agents EDTA and DTPA effectively remove toxic meta+s from the body, they also bind divalent calcium and zinc 4 and must 'be administered as the calcium or zinc salts to avoid depletion of these elements from the body. Even then, toxicity results when these ligands are administered to test animals over prolonged 5 periods.
Laboratory animals die, apparently at least in part as a result of Zn(II) depletion, when a high level of DTPA is maintained in the blood by multiple injections.
6 Thus, there is a need for development of chelating agents which are capable of selectively chelating the toxic metal without removing biologically significant divalent metal ions.
The in vivo sequestering of ferric ion is of particular interest because of its toxicity if in excess in the body. Using the microbial 7 8 iron sequestering agent enterobactin' as a model, synthetic catechoyl- 9 amide ligands have been designed to bind ferric ion. This work has recently been reviewed. 10
In addition to binding ferric ion, synthetic catechoylamide ligands will bind other metals with high charge to ionic radius ratios such as
: '
Pu(IV), the oxidation state most likely to exist under physiological conditions. Plutonium(IV) and Fe(III) possess 'notable chemical similarities: (1) they have similar charge to ionic radius ratios (4.Z and 4:.6 elA, respectively);ll (2) both have large hydrolysis constants;
and (3) Pu(IV) is known to follow biological iron transport pathways.12
With these similarities in mind, catechoylamide ligands were designed 13
,to bind Pu(IV), which is usually eight coordinate with bidentate ' .
' . . is the hydrogen ion concentration, not activity. Equilibrium constants were calculated by a weighted non-linear least-squares refinement in which the log a's were varied to minimize the sum of the differences between the observed and calculated pH at each point in the titration 20 curve.
Results and Discussion 4-LICAMS Titrations. The potentiometric titration curve of the free Figure 2. [The abscissa of the graph in this titration is moles base per mole ligand.] The curve shows a break at two equivalents. This is indicative of the deprotonation The ferric ion titration with 3,4,3-LICAMS breaks at ~ = 7. This is in keeping with the formation of a triscatecholate complex followed by deprotonation of the one remaining phenol which is ortho to the carbonyl.
The fact that only .~ catecholate arm is free in the fully formed ferric ion 3,4,3-LICAMS complex demonstrates that ferric ion more effectively employs the ligand denticity of 3,4,3-LICAMS than do the divalent metals.
Ferric ion also forms a stronger complex with 3,4,3-LICAMS.
Because of the expanded (octadentate), coordinating capabilities of 3,4,3-LICAMS,. titrations were also performed at two to one divalent metal to ligand ratios. These titration curves are shown in Figure 5 .
[For the free ligand curve, which is retained for the sake of comparison, the abscissa should read moles base per 1/2 mole ligand.] Note that divalent zinc, copper, cobalt, and nickel show definite breaks at ~ = 4, forming a dimer. The Ca(II) and Mg(II) curves indicate very weak complexation even at these higher metal concentrations. The relative stabilities are the same as in the previous complexes; this is reflected in the log a values given in Table II (a 2l0 ).
Attempts were made to titrate Mn(II) with MECAMS and 3,4,3-LICAMS.
All the titrations were characterized by large "drifts" in the pH readings. This can probably be attributed to the oxidation of Mn(II) The pM values for the divalent metals and ferric ion with 4-LICAMS, MECAMS; 3,4,3-LICAMS, EDTA, DTPA,and desferrioxamine B (DFO), the current chelating agent used for treatment of iron overload, are
tabulated in Table III . Using these numbers direct comparisons can be made: the larger the pM value, the greater the affinity of the chelate for the metal under the defined conditions. Under the conditions specified, the minim1.iIl1 pM value that is possible is 6.0. It is apparent from this study that 3,4,3-LICAMS demonstrates greater selectivity and greater 'affinity for metals of high charge to radius ratio than does DTPA, the current chelating agent used for plutonium decorporation. The difference in specificity between DTPA and 3,4,3-LICAMS confirms that catechoylamides may provide a promising alternative to DTPA for chelation therapy of plutonium contamination. 13 An interesting correlation is observed if one compares the pM value of each metal to its charge to ionic radius ratio. Figure 6 
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